Custom cover image
Custom cover image

The Economics of Pain : Regulation, Product Liability, and the Opioid Crisis / by John E. Schneider

By: Resource type: Ressourcentyp: Buch (Online)Book (Online)Language: English Series: Global Perspectives on Wealth and DistributionPublisher: Cham : Springer Nature Switzerland, 2026Publisher: Cham : Imprint: Palgrave Macmillan, 2026Description: 1 Online-Ressource (XVIII, 434 p. 30 illus., 21 illus. in color.)ISBN:
  • 9783032203557
Subject(s): Additional physical formats: 9783032203540 | 9783032203564 | 9783032203571 | Erscheint auch als: 9783032203540 Druck-Ausgabe | Erscheint auch als: 9783032203564 Druck-Ausgabe | Erscheint auch als: 9783032203571 Druck-AusgabeDDC classification:
  • 338.4761 23
DOI: DOI: 10.1007/978-3-032-20355-7Online resources: Summary: Chapter 1: Introduction -- Chapter 2: Product liability -- Chapter 3: Epidemiology -- Chapter 4: Causation -- Chapter 5: Responsibility -- Chapter 6: Attributable Costs -- Chapter 7: Abatement Costs -- Chapter 8: Remedies -- Chapter 9: Conclusion and Recommendations.Summary: “Economist John E. Schneider applies economic theory to the epidemic and ensuing litigation, exposing how regulatory breakdowns and institutional incentives fueled the crisis. Drawing on expert witness experience, Schneider challenges prevailing narratives and reframes how we understand—and address—complex public health failures.”—Michael Vinluan, MD, JD, FCLM, Past President, American College of Legal Medicine Product liability cases aimed at opioids have featured inflated damages and abatement costs, and responsibility for those costs has fallen on recognizable targets rather than true causal factors. Most opioid cases have ended in settlements, but such endings offer little in the way of closure to a problem that overwhelmed regulators and befuddled the entire medical profession. Courts were left to pick up the pieces, but the tools and data they were provided were woefully incomplete, with claimants incurring opioid-related costs but overstating future needs, and defendants unsure how to assess the impact of harms that they argued were too distant from their products—products that were used properly by the vast majority of users. This book synthesizes the information available following these court cases and breaks down the story of the opioid crisis from an economic perspective, rooted in the concepts of externalities, regulation, and organizational economics. Chapters analyze what happened, where things went wrong, and how we can work to reconfigure infrastructure that enabled the opioid crisis. Applying logical frameworks to often-reactionary systems, the book provides insight into product liability, epidemiology, the economics of externalities, regulatory failure, and alternative forms of governance. The resulting book helps readers confront the hardest-hitting questions, including: How could a crisis like this occur in one of the most regulated sectors of the economy? Will the lessons learned from the litigation prevent a situation like this from happening again? John E. Schneider is the co-founder and CEO of Avalon Health Economics LLC (AHE), a health economics consultancy focused on data-driven business analytics, health economics and outcomes research, litigation support, and policy analysis. He holds a BA and MA in economics from the University of Maine, and he earned a PhD in health economics from University of California, Berkeley.PPN: PPN: 1972281690Package identifier: Produktsigel: ZDB-2-SEB | ZDB-2-ECF | ZDB-2-SXEF
No physical items for this record

PDF/UA-1. Table of contents navigation. Single logical reading order. Short alternative textual descriptions. Use of color is not sole means of conveying information. Use of high contrast between text and background color. Next / Previous structural navigation. All non-decorative content supports reading without sight

KIT – The University in the Helmholtz Association                         Home | Legals | Privacy policy | KIT